XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Loss $ (4,358,282) $ (9,581,542)
Adjustments to reconcile consolidated net loss to net cash flows from operating activities    
Depreciation 2,415,139 3,067,556
Amortization 1,093,565 914,318
Loan cost amortization 103,180 279,951
Mandatorily redeemable preferred stock issuance cost and discount amortization 204,383 162,375
Convertible debenture issuance cost, discount and beneficial conversion feature amortization 1,718,487 119,870
Amortization of tenant inducements   7,100
Above (below) market lease amortization, net (24,024) 6,142
Bad debt expense 39,024 431,143
Note payable forgiveness (176,300) (129,600)
Share-based compensation 149,981 569,995
Impairment of assets held for sale   3,494,058
Loss on impairment   223,097
Gain on sale of investment property (124,641) 0
Changes in assets and liabilities    
Rent and other receivables, net (46,413) (740,513)
Unbilled rent (198,594) (212,840)
Other assets (50,243) (38,955)
Accounts payable and accrued liabilities 87,351 (257,089)
Net cash flows from operating activities 832,613 (1,684,934)
CASH FLOWS FROM INVESTING ACTIVITIES    
Investment property acquisitions, net of cash acquired and assumed debt (20,750,571)  
Capital expenditures (536,685) (414,361)
Cash received from disposal of investment properties 2,144,529  
Net cash flows from investing activities (19,142,727) (414,361)
CASH FLOWS FROM FINANCING ACTIVITIES    
Dividends and distributions paid (1,151,304) (917,733)
Investment of noncontrolling interests 504,000  
Proceeds from line of credit, short term, net   550,000
Repayment of line of credit, short term (325,000) (2,225,000)
Repayment of related party notes payable, short term   (852,000)
Proceeds from notes payable   305,900
Proceeds from mortgages payable, net 24,377,886 1,938,697
Repayment of mortgages payable (14,914,830) (463,196)
Proceeds from sale of mandatorily preferred stock, net of capitalized offering costs   3,860,882
Proceeds from sale of convertible debentures, net of capitalized offering costs 1,305,000 2,926,483
Proceeds from sales of common stock, net of capitalized offering costs 10,801,411  
Net cash flows from financing activities 20,597,163 5,124,033
INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 2,287,049 3,024,738
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period 5,096,928 2,072,190
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period $ 7,383,977 $ 5,096,928